Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Avalo Therapeutics, Inc. | 400,000 | reported | 04 Jan 2022 | tx 1+400,000 |
| Cartesian Therapeutics, Inc. | 100,000 | reported | 02 Jan 2020 | tx 6+553,812 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 04 Jan 2022 | GRANT_AWARD | Avalo Therapeutics, Inc. | 400,000 | 0.00 USD | deriv |
| 02 Jan 2020 | GRANT_AWARD | Cartesian Therapeutics, Inc. | 100,000 | 0.00 USD | deriv |
| 07 Oct 2019 | GRANT_AWARD | Cartesian Therapeutics, Inc. | 180,000 | 0.00 USD | deriv |
| 20 Aug 2019 | GRANT_AWARD | Cartesian Therapeutics, Inc. | 13,812 | 1.81 USD | |
| 07 Jan 2019 | GRANT_AWARD | Cartesian Therapeutics, Inc. | 100,000 | 2.60 USD | deriv |
| 15 Jun 2018 | GRANT_AWARD | Cartesian Therapeutics, Inc. | 80,000 | 0.00 USD | deriv |
| 17 Nov 2017 | GRANT_AWARD | Cartesian Therapeutics, Inc. | 80,000 | 0.00 USD | deriv |